Progesterone is used in IVF to prepare the uterine lining for embryo implantation and to sustain an early pregnancy until the placenta takes over hormone production, typically around week 12. Every IVF patient receives progesterone supplementation because the process of egg retrieval disrupts the body’s ability to produce enough of it on its own. Without supplementation, live birth rates drop significantly, from roughly 30% to 20% in frozen embryo transfer cycles.
Why Your Body Needs Extra Progesterone During IVF
In a natural menstrual cycle, ovulation leaves behind a small structure called the corpus luteum that pumps out progesterone steadily under signals from the pituitary gland. This hormone thickens the uterine lining and makes it receptive to a fertilized egg. During IVF, two things interfere with that process.
First, the medications used to prevent premature ovulation during egg stimulation suppress those pituitary signals. Second, the egg retrieval procedure physically removes follicular cells that would have formed the corpus luteum. The result is a gap in progesterone production right when it matters most. In frozen embryo transfer cycles using synthetic hormone preparation (called artificial cycles), there is no ovulation at all, so no corpus luteum forms. Progesterone must come entirely from supplementation.
Even in natural frozen transfer cycles where ovulation does occur, adding external progesterone can interfere with the delicate hormonal feedback loop that regulates the corpus luteum. This is one reason fertility specialists carefully tailor protocols to each patient rather than applying a one-size-fits-all approach.
When Progesterone Starts and How Long It Continues
The timing of your first progesterone dose is one of the most critical details in an IVF cycle. In a fresh transfer, supplementation typically begins the day after egg retrieval. In a frozen transfer, it starts once imaging confirms your uterine lining has reached the right thickness and your estrogen levels are adequate. The exact start date is carefully calculated because it must align with the developmental stage of the embryo being transferred. Starting even a day too early or too late can reduce the chance of implantation.
If the transfer results in a pregnancy, most clinics continue progesterone until approximately week 10 to 12 of pregnancy. By that point, the placenta has matured enough to produce its own progesterone, and external supplementation is no longer needed. Your fertility specialist will decide the exact stopping point based on your hormone levels and how your pregnancy is progressing.
How Progesterone Is Taken
There are three main routes for progesterone supplementation in IVF, and your clinic will recommend one based on your protocol, your body’s response, and practical considerations.
- Vaginal inserts or suppositories: These are the most commonly prescribed form. They deliver progesterone directly to the uterus, which means lower doses are needed and fewer whole-body side effects occur. They’re inserted two to three times daily.
- Intramuscular injections: Oil-based progesterone injected into the upper buttock muscle. These produce reliable, high blood levels and are often used in frozen transfer cycles. They require a long needle and can be painful, and many patients develop soreness or small knots at the injection site over weeks of daily use.
- Oral capsules: Sometimes used as a supplement alongside vaginal or injectable forms, though oral progesterone alone is generally considered less effective for IVF because the liver breaks down much of it before it reaches the uterus.
Some clinics use a combination of routes, particularly if blood levels need a boost. Serum progesterone levels around 10.6 ng/mL or higher on the day before blastocyst transfer are generally considered adequate, though target ranges vary by clinic.
Common Side Effects
Progesterone side effects overlap heavily with early pregnancy symptoms, which can make the two-week wait between transfer and pregnancy test particularly confusing. The most common effects include breast tenderness and swelling, bloating, constipation, nausea, fatigue, drowsiness, headaches, and mood swings. These are all considered normal and typically manageable.
Injection-specific issues are worth knowing about. Daily intramuscular shots can cause redness, swelling, or hard lumps at the injection site. Warming the oil vial in your hands before injecting, rotating injection sites, and applying a warm compress afterward can help. If you develop a localized rash or hive-like reaction, an over-the-counter antihistamine like cetirizine can provide relief. A true allergic reaction, with hives spreading beyond the injection site, difficulty breathing, or facial swelling, is rare but requires immediate medical attention.
For vaginal forms, local irritation and increased discharge are common. Some patients notice the carrier material from suppositories, which can look alarming but is normal.
What Happens if Progesterone Levels Are Too Low
Insufficient progesterone during the luteal phase (the window between transfer and early pregnancy) can prevent the uterine lining from sustaining an implanted embryo. Research published in Fertility and Sterility found that frozen transfer cycles with progesterone supplementation had a 30% live birth rate compared to 20% without it. That 10-percentage-point difference is substantial in fertility treatment, where every gain matters.
If your clinic monitors mid-cycle progesterone levels and finds them lower than expected, they may increase your dose, add a second delivery route, or adjust your protocol. This is one reason many clinics schedule blood draws in the days surrounding your transfer rather than relying solely on the initial prescription.
Why the Delivery Method Matters
The corpus luteum doesn’t just produce progesterone. It also secretes other hormones and substances that may help protect early pregnancy. Exogenous progesterone supplementation, no matter the route, cannot fully replicate this cocktail. Research in The Lancet noted that artificial hormone protocols in frozen transfers don’t reproduce the continuous, pulsatile secretion pattern of a natural corpus luteum. This is one reason some clinics prefer natural or modified natural frozen transfer cycles when possible, allowing the body’s own corpus luteum to contribute alongside supplementation.
For patients using vaginal progesterone, blood levels may appear deceptively low on lab work because the hormone concentrates in uterine tissue rather than circulating through the bloodstream. This doesn’t necessarily mean supplementation is failing. Your clinic will interpret your levels in context of the delivery method you’re using.